SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/16/1/20.09.24

SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/16/1/20.09.24 Share Price

DE000SU9SK36

Real-time Boerse Frankfurt Warrants 12:09:06 23/05/2024 BST
1.94 ^EUR	-4.43%

Current month	+141.67%
1 month	+322.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/16/1/20.09.24

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.	05-22	AQ
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-21	BU
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-21	AQ
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	05-17	MT

More news

Quotes 5-day view

Date	Price	Change
23/05/24	1.94	-4.43%
22/05/24	2.03	+11.54%
21/05/24	1.82	-3.19%
20/05/24	1.88	+14.63%
17/05/24	1.64	-1.20%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 12:09 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Société Générale
WKN	SU9SK3
ISIN	DE000SU9SK36
Date issued	22/02/2024
Strike	16 $
Maturity	20/09/2024 (121 Days)
Parity	1 : 1
Emission price	0.84 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	2.15 €
Lowest since issue	0.39 €
Delta	0.66x
Omega	5.048
Premium	7.89x
Gearing	7.63x
Moneyness	1.055
Difference Strike	-0.88 $
Difference Strike %	-5.50%
Spread	0.2 €
Spread %	9.35%
Theoretical value	2.040
Implied Volatility	42.01 %
Total Loss Probability	43.01 %
Intrinsic value	0.8115
Present value	1.229
Break even	18.21 €
Theta	-0.05x
Vega	0.03x
Rho	0.03x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company